After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Incyte Corp. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Incyte Corp. is $12.35B. A total of 1.05 million shares were traded on the day, compared to an average of 1.68M shares.
In the most recent transaction, Stein Steven H sold 7,365 shares of INCY for 65.51 per share on Jan 03 ’24. After the transaction, the EVP & Chief Medical Officer now owns 90,218 company shares. In a previous transaction on Jan 02 ’24, Iyengar Vijay K sold 657 shares at 65.00 per share. INCY shares that EVP, GMAPPS owns now total 43,412.
Among the insiders who sold shares, Tray Thomas disposed of 1,067 shares on Dec 13 ’23 at a per-share price of $62.37. This resulted in the Principal Accounting Officer holding 23,436 shares of INCY after the transaction. In another insider transaction, Tray Thomas sold 210 shares at $57.36 per share on Dec 12 ’23. Company shares held by the Principal Accounting Officer now total 24,503.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, INCY has a high of $75.74 and a low of $50.27.
As of this writing, INCY has an earnings estimate of $0.87 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $1.21 per share and a lower estimate of $0.6. The company reported an EPS of $1.1 in the last quarter, which was 7.80% higher than expectations of $1.02.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. INCY’s latest balance sheet shows that the firm has $2.35B in Cash & Short Term Investments as of fiscal 2021. There were $44.82M in debt and $854.31M in liabilities at the time. Its Book Value Per Share was $23.14, while its Total Shareholder’s Equity was $3.77B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INCY is Buy with a score of 3.95.
